This document evaluates different parameters for testing tablets, including size, shape, hardness, friability, weight variation, disintegration, and dissolution. It discusses how these parameters are measured using various instruments and test methods. The key parameters are evaluated to ensure tablets meet specifications according to pharmacopoeia standards like the USP and IP.
2. ACCORDING TO INDIAN PHARMACOPOEIA
PHARMACEUTICAL TABLET ARE SOLID , FLAT
OR BICONVEX DISHES ,UNIT DOSAGE FORM
,PREPARED BY A DRUG BY COMPRESSING A
MIXTURE OF DRUG OR DRUG WITH OR
WITHOUT DILUENT
3. EVALUATION PARAMETER
Size and shape
Hardness and friability
Weight variation
Disintegration
Dissolution
4. SIZE AND SHAPE
Measured by :-
Micrometer
Sliding caliper scale
Tablet thickness should be controlled within
±5% variation of standard value .
More likely to cause capping problem
5. WEIGHT VARIATION
ACCORDING TO USP ACCORDING TO IP
Average wt of tablet (mg)
130 or less less than
85
130 – 324 85 - 324
MT 324 MT 324
Max percentage
difference
allowed
10
7.5
5
6. INSTRUMENT USED FOR MEASUREMENT OF
HARDNESS
Monsanto tester
Strong & cobb tester
Pfizer tester
Erweka tester – kilogram
7. FRIABILITY TEST
Pre weighed tablet
sample placed in
friabilator
Operated 100 revolution
(25 rpm for 4 min)
Dropping tablet a
distance 6 inch
Tablet are then dusted
and reweighed
Conventional
compressed tablet that
lose less
than 0.5 to 1%of their
weight are generally
acceptable
8. DISINTEGRATION
6 test tube 3 inch
long
10 mesh screen
1 L beaker of water (0.1 N HCl)
simulated gastric fluid or
simulated
intestinal fluid
Temp 37±2 C
Up and down 5 – 6 cm
Frequency – 28 -32 cycle /
min
As per Indian
9. Official range not less than 95 %
Majority of tablet has disintegration time of
30 min.
Enteric coated tablet disintegration time is 2
hr in monograph
10. DISSOLUTION TEST
Stage no of unit dosage acceptance
unit test criteria
S1 6 no dosage unit
should be less
than Q+5
S2 6 average of 12
(S1
+S2)dosage unit
should be ≥ Q%
and no dosage unit
should be
less than Q-15%
11. S3 12 average of 24 (S1 + S2 +
S3)≥ Q% and not more than
two dosage unit are
less than Q – 15%
and no dosage unit
are less than Q – 25 %
Q percentage of drug content dissolved in given
time period
Acceptance citria based on Q value
12. 12
OFFICIAL DISSOLUTION MONOGRAPHS
United States Pharmacopeia
• USP XXX (30)
European Pharmacopoeia
• Ph. Eur. 5th Edition, Supplement
5.3
British Pharmacopoeia
• BP 2007
Japanese Pharmacopoeia
JP XIV (14)
13. OFFICIAL DISSOLUTION APPARATUS
Rotating Basket (Ph.Eur./BP/JP)
Paddle (Ph.Eur./BP/JP)
Flow Through Cell
(Ph.Eur./BP/JP)
Paddle Over Disk (Ph.Eur.)
14. APPARATUS 1 - BASKET
Useful for
• capsules
• beads
• delayed release / enteric
coated dosage forms
• floating dosage forms
• surfactants in media
Standard volume
• 900/1000 ml
• 1, 2, 4 liter vessels
15. APPARATUS 1 - BASKET
Advantages
• breadth of experience
(more than 200 monographs)
• full pH change during the test
• can be easily automated
which is important for routine
investigations
17. APPARATUS 2 - PADDLE
Useful for
• tablets
• capsules
• beads
• delayed release / enteric
coated dosage forms
Standard volume
• 900/1000 ml
Method of first choice !!!
18. APPARATUS 2 - PADDLE
Advantages
• easy to use
• long experience
• pH change possible
can be easily automated
which is important for
routine investigations
20. APPARATUS 3 – PADDLE OVER DISK
Useful for
• transdermal patches
Standard volume
• 900 ml
21. APPARATUS 3 – PADDLE OVER DISK
Advantages
• standard equipment
(paddle) can be used, only
add a stainless steel disk
assembly
Disadvantages
• disk assembly restricts
patch size